HemoDynamx
Treatment for Aortic Stenosis
Health Tech & Life Sciences
Stealth Mode
Company Overview
Snapshot
Founded in March 2014 by Jarret Fass and Sagy Karavany, HemoDynamx operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on developing medical devices for cardiovascular health.
Business overview
HemoDynamx is a cardiovascular medical device company focused on developing a treatment for aortic stenosis. The company's core technology aims to provide a profoundly simple solution for this condition, serving the healthcare providers within the broader healthcare and life sciences market. HemoDynamx operates within the Health Tech & Life Sciences sector, specifically targeting the Medical Devices and Medical Treatment & Therapeutics categories.
Company Intelligence Q&A
- What is HemoDynamx's primary focus?
- HemoDynamx is a cardiovascular medical device company developing a treatment for aortic stenosis.
- When was HemoDynamx founded?
- HemoDynamx was founded in March 2014.
- Who are the founders of HemoDynamx?
- The co-founders of HemoDynamx are Jarret Fass and Sagy Karavany.
- What industry sector does HemoDynamx operate in?
- HemoDynamx operates in the Health Tech & Life Sciences sector, with a focus on Medical Devices and Medical Treatment & Therapeutics.
- What is the current employee size of HemoDynamx?
- HemoDynamx currently has 1–10 employees.